Pregabalin overdose causing sinus bradycardia – A rare complication

Main Article Content

Rajesh Kumar*
Jathinder Kumar
Ihtisham Malik
Gordon Pate

Abstract

We present the unique case of severe, symptomatic bradycardia associated with pregabalin overdose. Pregabalin is a widely prescribed drug not routinely associated with sinus bradycardia. A 39 year old male, presented having taken about 4g of pregablin with intention to self-harm. Following admission, he subsequently developed bradycardia on telemetry. Other possible causes were excluded with serial investigations. The bradycardia resolved by 96 hours without the need for temporary pacing. Patients presenting with pregabalin overdose should be monitored for bradycardia.

Downloads

Download data is not yet available.

Article Details

Kumar, R., Kumar, J., Malik, I., & Pate, G. (2021). Pregabalin overdose causing sinus bradycardia – A rare complication. Journal of Cardiovascular Medicine and Cardiology, 8(1), 007–009. https://doi.org/10.17352/2455-2976.000160
Case Report(s)

Copyright (c) 2021 Kumar R, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45: 13-18. Link: https://bit.ly/3tWUIbA

Evoy KE, Morrison MD, Saklad SR (2017) Abuse and Misuse of Pregabalin and Gabapentin. Drugs 77: 403-426. Link: https://bit.ly/2Z9SXdc

Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ, et al. (2018) Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015. Clin Drug Investig 38: 373-380. Link: https://bit.ly/3qurleZ

Page RL, Cantu M, Lindenfeld J, Hergott LJ, Lowes BD (2008) Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown) 9: 922-925. Link: https://bit.ly/3pg4m5P

Pregabalin: cardiac adverse effects (2014) Prescrire Int 23: 45.Link: https://bit.ly/3jIGV3Z

Aksakal E, Bakirci EM, Emet M, Uzkeser M (2012) Complete atrioventricular block due to overdose of pregabalin. Am J Emerg Med 30: 2101.e1–2101.e21014. Link: https://bit.ly/3tXwhLw

Schiavo A, Stagnaro FM, Salzano A, Marra AM, Bobbio E, et al. (2017) Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis. Monaldi Arch Chest Dis 87: 838. https://bit.ly/3aVUOru

Pfizer Australia Pty Ltd (2005) lyrica( pregabalin), ABN 50 008 422 348 38 – 42 edn., Wharf Road West Ryde NSW 2114:pfizer.

Pexton T, Moeller-Bertram T, Schilling JM, Wallace MS (2011) Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 20: 1277-1284. Link: https://bit.ly/379Xdha

Ono K, Iijima T (2010) Cardiac T-type Ca(2+) channels in the heart. J Mol Cell Cardiol 48: 65-70. Link: https://bit.ly/2LKOv1i